Related Experiment Video
Updated: Feb 6, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Exploratory analysis for the implementation of antineoplastic logarithmic dose banding
A Albert-Marí1, S Valero-García2, V Fornés-Ferrer3
1Pharmacy Department, Área del Medicamento, Hospital Universitario y Politécnico La Fe, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain. albert_asu@gva.es.
Dose banding (DB) can streamline antineoplastic production in hospital pharmacies. This strategy allows for 40% of doses to be prepared in advance, improving efficiency and capacity.
Area of Science:
- Pharmaceutical Sciences
- Oncology Pharmacy Practice
- Healthcare Operations
Background:
- Dose banding (DB) is a strategy to rationalize antineoplastic production in hospital pharmacy aseptic compounding units (ACUs).
- DB aims to optimize workflows, reduce patient waiting times, and enhance safety, quality, and efficiency.
- Implementation of DB can facilitate the adoption of new technologies in compounding.
Purpose of the Study:
- To evaluate the impact of implementing Logarithmic Dose Banding (DB).
- To identify antineoplastic agents and preparations suitable for DB based on established criteria.
- To determine the number of standard doses that could be compounded in advance at the ACU.
Main Methods:
- A retrospective observational study analyzed antineoplastic dose production from December 2015 to May 2016.
- Investigational drugs were excluded. Three criteria were applied: >250 preparations/year, psychochemical stability for ≥14 days, and ≤5 logarithmic doses covering ≥60% of individual doses.
- The main outcome measured was the number of antineoplastic agents, preparations, and logarithmic standard doses suitable for DB.
Main Results:
- Analysis included 15,436 individual antineoplastic doses for 69 agents.
- Nineteen antineoplastic drugs (27%), including 3 monoclonal antibodies and 16 cytotoxic agents, were identified as candidates for DB.
- A significant portion, 6285 (40%) of compounded doses, could be prepared in advance as 84 logarithmic standard doses.
Conclusions:
- Dose banding implementation can rationalize antineoplastic production in hospital pharmacies.
- This strategy has the potential to significantly increase the compounding capacity of ACUs.
- Logarithmic dose banding offers a viable approach to improve efficiency and patient care in antineoplastic compounding.
More Related Videos
Related Concept Videos
Band Theory
The energy difference between these bands is known as the band gap.
Conductor, Semiconductor,...
Laws of Logarithms I
Applications of Logarithms
Laws of Logarithms II
Logarithmic Differentiation
Derivatives of Logarithmic Functions

